NewEdge Advisors’s Ocular Therapeutix OCUL Stock Holding History

NewEdge Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$13.7K	Hold	1,480	–	–	﹤0.01%	3087
2025 Q1	$10.8K	Hold	1,480	–	–	﹤0.01%	3070
2024 Q4	$12.6K	Hold	1,480	–	–	﹤0.01%	2963
2024 Q3	$12.9K	Hold	1,480	–	–	﹤0.01%	2865
2024 Q2	$10.1K	Hold	1,480	–	–	﹤0.01%	2856
2024 Q1	$13.5K	Hold	1,480	–	–	﹤0.01%	2769
2023 Q4	$6.6K	Hold	1,480	–	–	﹤0.01%	3020
2023 Q3	$4.65K	Sell	1,480 -11,000	-88%	-$34.5K	﹤0.01%	2836
2023 Q2	$64.4K	Buy	12,480 +11,000	+743%	+$56.8K	﹤0.01%	2005
2023 Q1	$7.8K	Sell	1,480 -9,000	-86%	-$47.4K	﹤0.01%	2645
2022 Q4	$29	Hold	10,480	–	–	﹤0.01%	3552
2022 Q3	$43K	Sell	10,480 -1,000	-9%	-$4.1K	﹤0.01%	1493
2022 Q2	$46K	Hold	11,480	–	–	﹤0.01%	1508
2022 Q1	$57K	Sell	11,480 -2,000	-15%	-$9.93K	﹤0.01%	1106
2021 Q4	$94K	Hold	13,480	–	–	﹤0.01%	1593
2021 Q3	$135K	Sell	13,480 -300	-2%	-$3K	﹤0.01%	1081
2021 Q2	$195K	Hold	13,780	–	–	0.01%	1054
2021 Q1	$226K	Sell	13,780 -5,373	-28%	-$88.1K	0.01%	912
2020 Q4	$396K	Sell	19,153 -2,827	-13%	-$58.5K	0.01%	688
2020 Q3	$167K	Sell	21,980 -2,000	-8%	-$15.2K	0.01%	849
2020 Q2	$200K	Sell	23,980 -500	-2%	-$4.17K	0.01%	775
2020 Q1	$121K	Sell	24,480 -1,500	-6%	-$7.41K	0.01%	736
2019 Q4	$102K	Buy	+25,980	New	+$102K	﹤0.01%	784
2019 Q3	–	Sell	-28,250	Closed	-$124K	–	838
2019 Q2	$124K	Sell	28,250 -8,000	-22%	-$35.1K	0.01%	630
2019 Q1	$144K	Hold	36,250	–	–	0.01%	639
2018 Q4	$144	Sell	36,250 -5,000	-12%	-$20	0.01%	597
2018 Q3	$284K	Hold	41,250	–	–	0.02%	510
2018 Q2	$271	Hold	41,250	–	–	0.02%	436
2018 Q1	$266K	Hold	41,250	–	–	0.03%	379
2017 Q4	$200K	Sell	41,250 -3,000	-7%	-$14.5K	0.03%	390
2017 Q3	$268K	Sell	44,250 -3,000	-6%	-$18.2K	0.04%	299
2017 Q2	$307K	Hold	47,250	–	–	0.05%	254
2017 Q1	$381K	Buy	+47,250	New	+$381K	0.09%	178